MétaCan
Menu
Back to cohort
Record W4409071443 · doi:10.1080/14796708.2025.2459587

Daily self-injection of zilucoplan improved symptoms in people with generalized myasthenia gravis in the RAISE clinical study: a Plain Language Summary of Publication

2025· article· en· W4409071443 on OpenAlexaff
James F. Howard, Kimiaki Utsugisawa, Maria Isabel Leite, Babak Boroojerdi, Mark Vanderkelen, Angela Genge

Bibliographic record

VenueFuture Neurology · 2025
Typearticle
Languageen
FieldMedicine
TopicMyasthenia Gravis and Thymoma
Canadian institutionsMontreal Neurological Institute and Hospital
Fundersnot available
KeywordsMyasthenia gravisMedicinePediatricsPsychologyPsychiatry

Abstract

fetched live from OpenAlex

Plain Language SummaryWhat is this summary about?This is a summary of an article that describes the results of the RAISE clinical study.Zilucoplan is being investigated as a treatment for an autoimmune disease called generalised myasthenia gravis. Conventional treatments for myasthenia gravis do not always work well and often have side effects that can limit their use. There is a need for new and improved treatments. The RAISE clinical study looked at whether subcutaneous (under the skin) zilucoplan injections taken once per day were better than a placebo at treating symptoms of generalised myasthenia gravis.What were the results?People who took zilucoplan for 12 weeks had a rapid (after 1 week) and clinically meaningful improvement of symptoms of generalised myasthenia gravis, compared with people who took placebo. The most common side effects during the study were mild bruising at the site of injection and headache.What do the results mean?The results mean that zilucoplan was an effective treatment for myasthenia gravis and had favourable safety results. The efficacy and safety of zilucoplan when taken for longer than 12 weeks are being assessed in an extension of this study.How to say…Zilucoplan: Zi-LOO-co-PLAN or Zy-LOO-co-PLANMyasthenia gravis: My-as-THEEN-ee-a GRAH-vissPlacebo: Pluh-SEE-bohAcetylcholine: A-SIT-ile-KOH-leenSide effects: Unintended effects while taking a medication.Placebo: A medicine that looks and feels (and, if relevant, tastes) the same as the active treatment, but contains no active ingredients. A placebo may be used in clinical studies to ensure patients and doctors are not biased when completing assessments of symptoms, by making sure they remain unaware of whether the patient is on treatment or not.Clinically meaningful improvement: For myasthenia gravis, an improvement of 2 or more points in the MG-ADL score and an improvement of 3 or more in MGC and QMG scores is considered to be clinically meaningful. This level of improvement is likely to be large enough to be relevant to patients.Efficacy: The ability of a drug to produce a desired effect.Extension: An additional period after the observational period during which patients can continue to take the medication if they wish. The extension period helps to understand the safety and efficacy of a treatment over a longer period of time than the initial clinical trial period.This is an abstract of the Plain Language Summary of Publication article.View the full Plain Language Summary PDF of this article to read the full-textLink to original article hereTrial registration: ClinicalTrials.gov identifier: NCT04115293.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.410

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.280
Teacher spread0.274 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueFuture NeurologySame topicMyasthenia Gravis and ThymomaFrench-language works237,207